Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
bioLytical Laboratories announced that the Food and Drug Administration (FDA) has approved its INSTI HIV Antibody Test for the detection of antibodies to HIV type 2 (HIV-2). With this approval, the INSTI HIV-1/2 Antibody Test is available for use in detecting both HIV-1 and HIV-2 antibodies.
RELATED: Over 90% of New HIV Infections Could Be Prevented With Tx, Care
The INSTI HIV-1/2 Antibody Test is a single-use, rapid, in vitro qualitative immunoassay that can detect antibodies in 60 seconds in human venipuncture whole blood, fingerstick blood, or plasma specimens. The FDA’s approval also includes a CLIA waiver, allowing the test to be performed outside a laboratory setting by anyone who has been trained.
For more information call (604) 204-6784 or visit Biolytical.com.
